Basic information Safety Supplier Related

Tegaserod

Basic information Safety Supplier Related

Tegaserod Basic information

Product Name:
Tegaserod
Synonyms:
  • TEGASEROD
  • 2-[(5-methoxy-1h-indol-3-yl)methylene]-n-pentylhydrazine-carboximidamide
  • Tegaserode
  • Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-
  • Tegaserod USP/EP/BP
  • Tegaserod 13CD3Q: What is Tegaserod 13CD3 Q: What is the CAS Number of Tegaserod 13CD3
  • Tegaserod D10Q: What is Tegaserod D10 Q: What is the CAS Number of Tegaserod D10
  • Tegaserod D11 (Major-D10)Q: What is Tegaserod D11 (Major-D10) Q: What is the CAS Number of Tegaserod D11 (Major-D10)
CAS:
145158-71-0
MF:
C16H23N5O
MW:
301.39
Mol File:
145158-71-0.mol
More
Less

Tegaserod Chemical Properties

Melting point:
155°
Boiling point:
470.6±48.0 °C(Predicted)
Density 
1.18
storage temp. 
2-8°C
form 
Solid
pka
15.81±0.30(Predicted)
color 
White to off-white
CAS DataBase Reference
145158-71-0(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
20/21/22-36/37/38
Safety Statements 
36/37-36-26
More
Less

Tegaserod Usage And Synthesis

Uses

Treatment of gastrointestinal motility disorders (selective serotonin 5HT4antagonist).

Indications

Tegaserod (Zelnorm) is serotonin-4 (5-HT4) receptor agonists that stimulate GI motility.

Definition

ChEBI: Tegaserod is a member of guanidines, a carboxamidine, a member of hydrazines and a member of indoles. It has a role as a serotonergic agonist and a gastrointestinal drug.

brand name

Zelmac (Novartis).

Clinical Use

Tegaserod is being developed as a treatment for constipation- predominant irritable bowel syndrome (IBS). Within the first week, patients treated with tegaserod had significant improvements in abdominal pain and discomfort, constipation, and overall well-being. Efficacy was maintained throughout the treatment period. Tegaserod also demonstrated significant improvements in the three bowel-related assessments (stool frequency, stool consistency, and straining) within the first week, and these improvements were sustained throughout the treatment period. The most common adverse events reported thus far are headache and diarrhea.

TegaserodSupplier

XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768850
Email
1791901229@qq.com
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Email
waley188@sohu.com
Shanghai Raise Chemical Technology Co.,Ltd
Tel
+86-021-50935922
Shanghai Meishui Chemical Technology Co., Ltd
Tel
021-60549325 18616193163
Chengdu HuaXia Chemical Reagent Co. Ltd
Tel
400-1166-196 13458535857
Email
cdhxsj@163.com